What is ALMR's Value Score?

Alamar Biosciences, Inc. (ALMR) has a StockPik Value Score of 35 out of 100 — a low score, indicating weak value characteristics. The Value Score is a composite ranking built from P/E ratio, P/B ratio, Graham Number, ROE, gross margin, debt-to-equity, current ratio, and Piotroski F-Score, calculated from SEC EDGAR annual filing data.

What is ALMR's Piotroski F-Score?

Alamar Biosciences, Inc. (ALMR) has a Piotroski F-Score of 0 out of 9 — a weak score indicating financial deterioration across multiple criteria. The F-Score assesses nine binary financial criteria across profitability, leverage, and operating efficiency. A score of 7–9 indicates a financially improving company; a score of 0–3 is a warning sign.

What is ALMR's Piotroski F-Score?

ALMR's Piotroski F-Score is 0 out of 9, indicating weak financial health and possible deterioration. The Piotroski F-Score evaluates nine criteria across profitability, leverage, and operating efficiency. Scores of 7 or above are considered strong; 3 or below indicate financial weakness.

Is ALMR (Alamar Biosciences, Inc.) undervalued?

ALMR scores 35/100 on StockPik's Value Score.

Back to Screener

Alamar Biosciences, Inc. (ALMR)

NASDAQ Small Cap

$20.54

Market Cap: $1.4B

Data as of Jun 30, 2026 (TTM)

Price History

Apr 19, 2026 — Sep 1, 2026

Investment Snapshot

P/B of 4.56 — trading above book value
Piotroski F-Score 0/9 — signs of financial weakness
Loss-making — negative ROE of -15.7%

Alamar Biosciences, Inc. (ALMR) is a publicly traded company, listed on the NASDAQ , with a market capitalisation of $1.4 billion . Key value metrics: P/B ratio 4.56, Piotroski F-Score 0 out of 9 .

Value Score

out of 100

Try PRO Free — See Full Breakdown

Key Metrics

P/E Ratio

—

P/B Ratio

4.56

EPS

$-0.71

Div. Yield

—

PEG Ratio

—

P/S Ratio

—

EV/EBITDA

—

ROE

—

ROA

—

Gross Margin

—

Op. Margin

—

Net Margin

—

Debt/Equity

—

Current Ratio

—

Unlock 19 More Metrics — 7 Days Free

Financial Statements

Metric	FY22	FY23	FY24
Revenue	$X.XB	$X.XB	$X.XB
Gross Profit	$X.XB	$X.XB	$X.XB
Operating Income	$X.XB	$X.XB	$X.XB
Net Income	$X.XB	$X.XB	$X.XB
EBITDA	$X.XB	$X.XB	$X.XB
Total Assets	$X.XB	$X.XB	$X.XB
Total Liabilities	$X.XB	$X.XB	$X.XB

Unlock 5 Years of Financials — Start Free Trial

Data sourced from SEC EDGAR and Polygon.io. Methodology.

Alamar Biosciences, Inc. — Fundamental Analysis Summary

On financial health, ALMR shows a weak Piotroski F-Score of 0/9, a signal of deteriorating financial health, and negative return on equity of -15.7%.

StockPik's composite Value Score for ALMR is 35/100 — reflecting current market or financial concerns. The score is built from ten fundamental signals: P/E, P/B, PEG ratio, P/S ratio, return on equity, gross margin, debt-to-equity, current ratio, dividend yield, and Piotroski F-Score.

ALMR reports a solid gross margin of 55.7% and a negative operating margin of -50.0%.

How is the Value Score calculated?

Read our full methodology →

What is the Piotroski F-Score?

The 9-point financial health score explained, with worked examples →

ALLY — Ally Financial Inc. Common Stock

Alumis Inc. - Common Stock — ALMS